BioNeutra Global Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CAD 3.254 million compared to CAD 7.166 million a year ago. Net loss was CAD 1.390 million compared to CAD 1.124 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago.